Literature DB >> 6317894

Direct demonstration that the abundant 6-kilobase herpes simplex virus type 1 mRNA mapping between 0.23 and 0.27 map units encodes the major capsid protein VP5.

R H Costa, G Cohen, R Eisenberg, D Long, E Wagner.   

Abstract

The two partially colinear 6-kilobase (kb) and 1.5-kb mRNAs mapping between 0.23 and 0.27 map units on the herpes simplex virus type 1 genome were precisely located. The 5' end of the 6-kb mRNA was located 28 bases downstream of the sequence ATATATT and was 10 bases to the left of the BamHI site at 0.268. This position is ca. 90 bases to the left of our earlier reported sequence (R. J. Frink, K. G. Draper, and E. K. Wagner, Proc. Natl. Acad. Sci. U.S.A. 78:6139-6143, 1981). We used a polyclonal antibody made against purified herpes simplex virus type 1 VP5 to demonstrate that the 155,000-dalton translation product of the 6-kb mRNA is this capsid protein. The antibody did not react with the 35,000-dalton translation product of the 1.5-kb mRNA. We also confirmed our identification of VP5 as the translation product of the 6-kb mRNA by comparison of tryptic peptides of the in vitro-translated protein and authentic VP5.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6317894      PMCID: PMC255457     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Uninfected cell polymerase efficiently transcribes early but not late herpes simplex virus type 1 mRNA.

Authors:  R J Frink; K G Draper; E K Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

2.  Characterization of a major late herpes simplex virus type 1 mRNA.

Authors:  R H Costa; B G Devi; K P Anderson; B H Gaylord; E K Wagner
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

3.  Detailed characterization of an apparently unspliced beta herpes simplex virus type 1 gene mapping in the interior of another.

Authors:  K G Draper; R J Frink; E K Wagner
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

4.  Is ribonucleotide reductase the transforming function of herpes simplex virus 2?

Authors:  D Huszar; S Bacchetti
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

5.  Ribonucleotide reductase induced by herpes simplex virus has a virus-specified constituent.

Authors:  B M Dutia
Journal:  J Gen Virol       Date:  1983-03       Impact factor: 3.891

6.  Detection by RNA blot hybridization of RNA sequences homologous to the BglII-N fragment of herpes simplex virus type 2 DNA.

Authors:  F J Jenkins; M K Howett; D J Spector; F Rapp
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

7.  Identification of proteins encoded by a fragment of herpes simplex virus type 2 DNA that has transforming activity.

Authors:  D A Galloway; L C Goldstein; J B Lewis
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

8.  Herpes simplex virus mRNA species mapping in EcoRI fragment I.

Authors:  L M Hall; K G Draper; R J Frink; R H Costa; E K Wagner
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

9.  High-resolution characterization of herpes simplex virus type 1 transcripts encoding alkaline exonuclease and a 50,000-dalton protein tentatively identified as a capsid protein.

Authors:  R H Costa; K G Draper; L Banks; K L Powell; G Cohen; R Eisenberg; E K Wagner
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

10.  Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C.

Authors:  R J Frink; R Eisenberg; G Cohen; E K Wagner
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

View more
  24 in total

1.  Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray.

Authors:  S W Stingley; J J Ramirez; S A Aguilar; K Simmen; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in trans.

Authors:  R H Persson; S Bacchetti; J R Smiley
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

3.  An unusual spliced herpes simplex virus type 1 transcript with sequence homology to Epstein-Barr virus DNA.

Authors:  R H Costa; K G Draper; T J Kelly; E K Wagner
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  A single regulatory region modulates both cis activation and trans activation of the herpes simplex virus VP5 promoter in transient-expression assays in vivo.

Authors:  E D Blair; E K Wagner
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

5.  Regulation of transcription in vitro from herpes simplex virus genes.

Authors:  L I Pizer; D G Tedder; J L Betz; K W Wilcox; P Beard
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

6.  The promoter for the late gene encoding Vp5 of herpes simplex virus type 1 is recognized by cell extracts derived from uninfected cells.

Authors:  G E Chisholm; W C Summers
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  Molecular basis of the glycoprotein-C-negative phenotype of herpes simplex virus type 1 macroplaque strain.

Authors:  K G Draper; R H Costa; G T Lee; P G Spear; E K Wagner
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

8.  Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA.

Authors:  P Desai; N A DeLuca; J C Glorioso; S Person
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Mutational analysis of sequences downstream of the TATA box of the herpes simplex virus type 1 major capsid protein (VP5/UL19) promoter.

Authors:  C J Huang; S A Goodart; M K Rice; J F Guzowski; E K Wagner
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  The UL21 gene products of herpes simplex virus 1 are dispensable for growth in cultured cells.

Authors:  J D Baines; A H Koyama; T Huang; B Roizman
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.